MedTrace Logo

Endtidalcarbondioxide Monitoring

NCT04177927 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2021-10-08

No results posted yet for this study

Summary

Does Endtidalcarbondioxide Monitoring in Gastrointestinal Endoscopy Have a Clinical Advantage?

Conditions

  • Gastrointestinal Dysfunction

Interventions

DEVICE

Capnostream 20p / Coviden

The special nasal canule is used for detection carbondioxide from breathe of patients

DEVICE

Rutine monitoring

peripheric Oxygen saturation is monitored.

Sponsors & Collaborators

  • Istanbul Medeniyet University

    lead OTHER

Principal Investigators

  • Nurten Bakan, doctor · Ministry of Health University

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2020-07-01
Completion
2020-10-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04177927 on ClinicalTrials.gov